Effect of CPAP treatment on endothelial function and plasma CRP levels in patients with sleep apnea

Medical Science Monitor

Volumn 18, Issue 12, 2012, Pages

  Panoutsopoulos, Athanasios ^a   Kallianos, Anastasios ^b   Kostopoulos, Konstantinos ^b   Seretis, Charalampos ^c   Koufogiorga, Eleni ^b   Protogerou, Athanasios ^b   Trakada, Georgia ^b   Kostopoulos, Charalampos ^b   Zakopoulos, Nikolaos ^b   Nikolopoulos, Ioannis ^b  

^a General Hospital of Argos   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

Author keywords

CPAP; Inflammation; Sleep apnea

Indexed keywords

C REACTIVE PROTEIN;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD ANALYSIS; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MALE; POSITIVE END EXPIRATORY PRESSURE; SLEEP DISORDERED BREATHING; SLEEP QUALITY; VASCULAR ENDOTHELIUM;

BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; ENDOTHELIUM, VASCULAR; HUMANS; MALE; SLEEP; SLEEP APNEA, OBSTRUCTIVE;

EID: 84874762466     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883603     Document Type: Article

References (39)

1. Patil SP, Schneider H, Schwartz AR, Smith PL: Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest, 2007; 132: 325-37
2. Young T, Peppard PE, Gottlieb DJ: Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med, 2002; 165: 1217-39
3. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med, 2000; 342: 1378-84
4. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005; 365: 1046-53
5. Wang P, Zweier JL: Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite mediated reperfusion injury. J Biol Chem, 1996; 271: 29223-30
6. Liao JK, Zulueta JJ, Yu FS et al: Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest, 1995; 96: 2661-66
7. Santos-García D, Rodríguez-Yáñez M, Arias-Rivas S, Blanco M: Brachial arterial flow mediated dilation: utility in clinical and experimental practice. Rev Neurol, 2011; 53: 351-60
8. Thijssen DH, Black MA, Pyke KE et al: Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol, 2011; 300: H2-12
9. Sert Kuniyoshi FH, Singh P, Gami AS et al: Patients with obstructive sleep apnea exhibit impaired endothelial function after myocardial infarction. Chest, 2011; 140: 62-67
10. Yim-Yeh S, Rahangdale S, Nguyen AT et al: Obstructive sleep apnea and aging effects on macrovascular and microcirculatory function. Sleep, 2010; 33: 1177-83
11. Yim-Yeh S, Rahangdale S, Nguyen AT et al: Vascular dysfunction in obstructive sleep apnea and type 2 diabetes mellitus. Obesity (Silver Spring), 2011; 19: 17-22
12. Madjid M, Willerson JT: Inflammatory markers in coronary heart disease. Br Med Bull, 2011; 100: 23-38
13. Rus H, Niculescu FI: Inflammation, aspirin, and the risk of cardiovascular disease. N Engl J Med, 1997; 337: 423; author reply 423-24
14. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B: Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J, 2005; 46: 801-9
15. Firat Guven S, Turkkani MH, Ciftci B et al: The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep Breath, 2012; 16: 217-21
16. Lui MM, Lam JC, Mak HK et al: C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest, 2009; 135: 950-56
17. Park JG, Ramar K, Olson EJ: Updates on definition, consequences, and management of obstructive sleep apnea. Mayo Clin Proc, 2011; 86: 549-54; quiz 554-55
18. Corretti MC, Anderson TJ, Benjamin EJ et al: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol, 2002; 39: 257-65
19. Simova I, Katova T, Denchev S: Diagnostic accuracy of flow-mediated dilatation and intima-media thickness for the presence of significant coronary artery disease. J Am Soc Hypertens, 2009; 3: 388-94
20. Yeboah J, Folsom AR, Burke GL et al: Predictive value of brachial flowmediated dilation for incident cardiovascular events in a populationbased study: the multi-ethnic study of atherosclerosis. Circulation, 2009; 120: 502-9
21. Su Y, Liu XM, Sun YM et al: Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus. Am J Cardiol, 2008; 102: 497-98
22. Kato M, Roberts-Thomson P, Phillips BG et al: Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation, 2000; 102: 2607-10
23. Shirai M, Pearson JT, Shimouchi A et al: Changes in functional and histological distributions of nitric oxide synthase caused by chronic hypoxia in rat small pulmonary arteries. Br J Pharmacol, 2003; 139: 899-910
24. Phillips BG, Narkiewicz K, Pesek CA et al: Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens, 1999; 17: 61-66
25. Møller DS, Lind P, Strunge B, Pedersen EB: Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens, 2003; 16: 274-80
26. Ip MSM, Tse HF, Lam B, Tsang KWT, Lam WK: Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med, 2004; 169: 348-53
27. Bayram NA, Ciftci B, Keles T et al: Endothelial function in normotensive men with obstructive sleep apnea before and 6 months after CPAP treatment. Sleep, 2009; 32: 1257-63
28. Kaptoge S, Di Angelantonio E, Lowe G et al: C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet, 2010; 375: 132-40
29. Shamsuzzaman AS, Winnicki M, Lanfranchi P et al: 2002. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation, 2002; 105: 2462-64
30. Schulz R, Mahmoudi S, Hattar K et al: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Am J Respir Crit Care Med, 2000; 162: 566-70
31. Browning LM, Krebs JD, Magee EC et al: Circulating markers of inflammation and their link to indices of adiposity. Obes Facts, 2008; 1: 259-65
32. Chung S, Yoon IY, Shin YK et al: Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome. Sleep, 2007; 30: 997-1001
33. Verma S, Wang CH, Lonn E et al: Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individuals. Eur Heart J, 2004; 25: 1754-60
34. Nyström T, Nygren A, Sjöholm A: Persistent endothelial dysfunction is related to elevated C-reactive protein (CRP) levels in Type II diabetic patients after acute myocardial infarction. Clin Sci (Lond), 2005; 108: 121-28
35. Yokoe T, Minoguchi K, Matsuo H et al: Elevated levels of Creactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation, 2003; 107: 1129-34
36. Schiza SE, Mermigkis C, Panagiotis P et al: C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy. Eur J Clin Invest, 2010; 40: 968-75
37. Ishida K, Kato M, Kato Y et al: Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest, 2009; 136: 125-29
38. Korostovtseva LS, Sviryaev YV, Zvartau NE et al: Prognosis and cardiovascular morbidity and mortality in prospective study of hypertensive patients with obstructive sleep apnea syndrome in St Petersburg, Russia. Med Sci Monit, 2011; 17(3): CR146-53
39. Zirlik S, Hauck T, Fuchs FS et al: Leptin, obestatin and apelin levels in patients with obstructive sleep apnoea syndrome. Med Sci Monit, 2011; 17(3): 159-64